Market Research Logo

Oramed Pharmaceuticals Inc (ORMP) - Financial and Strategic SWOT Analysis Review

Oramed Pharmaceuticals Inc (ORMP) - Financial and Strategic SWOT Analysis Review

- provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

  • Business description – A detailed description of the company’s operations and business divisions.
  • Corporate strategy – Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history – Progression of key events associated with the company.
  • Major products and services – A list of major products, services and brands of the company.
  • Key competitors – A list of key competitors to the company.
  • Key employees – A list of the key executives of the company.
  • Executive biographies – A brief summary of the executives’ employment history.
  • Key operational heads – A list of personnel heading key departments/functions.
  • Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
  • Key manufacturing facilities – A list of key manufacturing facilities of the company.
  • Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Highlights

Oramed Pharmaceuticals Inc (Oramed) engages in the research and development of novel pharmaceutical solutions, comprising an oral insulin capsule for the treatment of individuals with diabetes, and orally ingestible capsules or pills for delivery of other polypeptides. It developed a unique proprietary platform technology, Protein Oral Delivery (POD) to transform injectable treatments into oral therapies. The technology allows for the oral delivery of drugs currently administered only by injection. The company tested its technology through various animal and human studies on its two flagship products, ORMD-0801, an orally ingestible insulin capsule; and ORMD-0901, an oral GLP-1 analog (exenatide) capsule. Oramed is headquartered in Jerusalem, Israel.

Oramed Pharmaceuticals Inc Key Recent Developments

Jul 21,2017: Oramed Pharma CFO resigns
Jul 18,2017: Oramed Pharmaceuticals appoints vice president of medical affairs
Mar 22,2017: Oramed to Present at Oligonucleotide and Peptide Therapeutics (OPT) Boston Conference on March 28, 2017
Mar 21,2017: Oramed Appoints Dr. Ronald Law as Chief Strategy Officer

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company


Section 1 - About the Company
Oramed Pharmaceuticals Inc - Key Facts
Oramed Pharmaceuticals Inc - Key Employees
Oramed Pharmaceuticals Inc - Key Employee Biographies
Oramed Pharmaceuticals Inc - Major Products and Services
Oramed Pharmaceuticals Inc - History
Oramed Pharmaceuticals Inc - Company Statement
Oramed Pharmaceuticals Inc - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Joint Venture
Section 2 – Company Analysis
Company Overview
Oramed Pharmaceuticals Inc - Business Description
Oramed Pharmaceuticals Inc - Corporate Strategy
Oramed Pharmaceuticals Inc - SWOT Analysis
SWOT Analysis - Overview
Oramed Pharmaceuticals Inc - Strengths
Oramed Pharmaceuticals Inc - Weaknesses
Oramed Pharmaceuticals Inc - Opportunities
Oramed Pharmaceuticals Inc - Threats
Oramed Pharmaceuticals Inc - Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
Oramed Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018
Oramed Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018
Oramed Pharmaceuticals Inc, Recent Deals Summary
Section 5 – Company’s Recent Developments
Jul 18, 2017: Oramed Pharmaceuticals appoints vice president of medical affairs
Mar 22, 2017: Oramed to Present at Oligonucleotide and Peptide Therapeutics (OPT) Boston Conference on March 28, 2017
Mar 21, 2017: Oramed Appoints Dr. Ronald Law as Chief Strategy Officer
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer
List of Tables
Oramed Pharmaceuticals Inc, Key Facts
Oramed Pharmaceuticals Inc, Key Employees
Oramed Pharmaceuticals Inc, Key Employee Biographies
Oramed Pharmaceuticals Inc, Major Products and Services
Oramed Pharmaceuticals Inc, History
Oramed Pharmaceuticals Inc, Subsidiaries
Oramed Pharmaceuticals Inc, Joint Venture
Oramed Pharmaceuticals Inc, Key Competitors
Oramed Pharmaceuticals Inc, Ratios based on current share price
Oramed Pharmaceuticals Inc, Annual Ratios
Oramed Pharmaceuticals Inc, Annual Ratios (Cont...1)
Oramed Pharmaceuticals Inc, Interim Ratios
Oramed Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018
Oramed Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018
Oramed Pharmaceuticals Inc, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios
List of Figures
Oramed Pharmaceuticals Inc, Performance Chart (2013 - 2017)
Oramed Pharmaceuticals Inc, Ratio Charts
Oramed Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018
Oramed Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report